Previous close | 387.88 |
Open | 385.57 |
Bid | 409.40 |
Ask | 417.10 |
Strike | 370.00 |
Expiry date | 2024-06-21 |
Day's range | 385.57 - 387.88 |
Contract range | N/A |
Volume | |
Open interest | 20 |
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
The market rally stumbled ahead of the Fed meeting. Amazon and AI plays Super Micro and AMD reported earnings late.
Eli Lilly stock jumped Tuesday despite a mixed first-quarter report, after sales of weight-loss drug Zepbound obliterated expectations.